Piao et al. (2013) reported that the HA receptor CD44 was expressed by OPCs and involved in the in vitro migration of those cells toward sites of high HA concentration, like those surrounding damaged lesions in the MS and EAE tissues in this study. The gene discussed is CD44; the disease is myeloid sarcoma.